Cargando...
Factor XIa inhibitors: A review of patent literature
INTRODUCTION: Anticoagulants are the mainstay for prevention and/or treatment of thrombotic disorders. Each clinically used anticoagulant is associated with significant adverse consequences, especially bleeding. Factor XIa (FXIa), a key factor involved in the amplification of procoagulation signal,...
Gardado en:
| Publicado en: | Expert Opin Ther Pat |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941829/ https://ncbi.nlm.nih.gov/pubmed/26881476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543776.2016.1154045 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|